©The Author(s) 2025.
World J Gastrointest Endosc. Nov 16, 2025; 17(11): 110436
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.110436
Published online Nov 16, 2025. doi: 10.4253/wjge.v17.i11.110436
Table 3 Clinical and endoscopic outcomes (n = 79)
| n (%) | |
| Mean follow-up, months, mean ± SD | 26.3 ± 21.8 |
| Early follow-up (3-6 months) | |
| Residual adenoma | 4 (5.1) |
| Management of residual adenoma | |
| EMR | 2 (2.5) |
| ESD | 2 (2.5) |
| Late follow up (> 6 months) | |
| Mean time to recurrence ± SD, months | 18.0 ± 15 |
| Recurrent adenoma | |
| Local | 9 (11.4) |
| Metachronous | 1 (1.3) |
| Management of recurrent adenoma | |
| EMR | 6 (7.6) |
| ESD | 4 (5.1) |
| Pathology of recurrent adenoma | |
| LGD | 7 (8.9) |
| HGD | 2 (2.5) |
| Intramucosal adenocarcinoma (T1a) | 1 (1.3) |
- Citation: El-Domiaty N, Beuvon F, Carpentier-Pourquier M, Ibrahim W, Oumrani S, Doumbe-Mandengue P, Belle A, Chaussade S, Pellat A, Shiha G, Coriat R, Barret M. Subtype-specific risk factors for gastric adenomas and independent predictors of recurrence after endoscopic resection. World J Gastrointest Endosc 2025; 17(11): 110436
- URL: https://www.wjgnet.com/1948-5190/full/v17/i11/110436.htm
- DOI: https://dx.doi.org/10.4253/wjge.v17.i11.110436